Slow Medicine/Choosing Wisely Italy e la medicina di laboratorio

Author(s):  
Sandra Vernero
2022 ◽  
Vol 4 ◽  
pp. e4222
Author(s):  
Marco Bobbio ◽  
Sandra Vernero ◽  
Domenico Colimberti ◽  
Andrea Gardini

Choosing Wisely® is an initiative of the American Board of Internal Medicine Foundation to help physicians and patients engage in conversations about the overuse of tests and procedures and support physician efforts to help patients make smart and effective care choices. Choosing Wisely campaigns are now active and present in 25 countries around the world, on five continents. Italy is the only country where a Choosing Wisely campaign was launched, and it is currently steered by a Nationwide association (Slow Medicine), creating a synergistic alliance. The Slow Medicine Association was founded in 2011 when a group of health professionals and citizens shared a new paradigm of values, methodology, and interventions and decided to establish an association with the mission of working for a health system driven by ethics and quality principles. Three keywords summarize the philosophy of Slow Medicine: measured because it acts with moderation, gradualness, and without waste; respectful because it is attentive to the dignity of individuals recognizing their values; and equitable because it is committed to ensuring appropriate care based on the best available evidence. Slow Medicine allowed the spread of Choosing Wisely in Italy involving several professional societies and participating at the National meetings of the Societies as well as numerous other meetings, in which the mission of the Association is combined with the principle of the ‘do not’ recommendations. Numerous other initiatives were carried out, and new projects were planned in synergy with Choosing Wisely.


2015 ◽  
Vol 13 (1) ◽  
Author(s):  
Enrico Heffler ◽  
Massimo Landi ◽  
Silvana Quadrino ◽  
Cristoforo Incorvaia ◽  
Stefano Pizzimenti ◽  
...  

2019 ◽  
Vol 89 (2) ◽  
Author(s):  
Marco Bobbio ◽  
Sandra Vernero

The philosophy and the history of the International Choosing Wisely movement, launched in the U.S. in 2012, are described. It grew and spread beyond what it was anticipated at the beginning because there is a rising concern of the medical community regarding the appropriate use of procedures and treatments placed into the market before an adequate evaluation of risks and benefits. Not only healthcare providers, but also patients, citizens and politicians, are becoming aware of the consequences of inappropriate decisions and behaviors since inappropriateness has economic (waste of resources), clinical (risks), but also ethical implications. In Italy the movement was launched and still is coordinated by the Slow Medicine organization, that created the campaign Doing more does not mean doing better – Choosing Wisely Italy, which aimed to improve clinical appropriateness through the reduction of unnecessary tests and treatments and the dialogue between physicians and patients. Currently, 44 societies of physicians, nurses, pharmacists and physiotherapists identified 230 recommendations about tests, treatments and procedures commonly used in Italy’s clinical practice that do not provide any benefit to most patients but may cause harm.


2019 ◽  
Vol 89 (2) ◽  
Author(s):  
Marika Werren ◽  
Roberto Copetti ◽  
Nicola Gaibazzi ◽  
Franco Giada ◽  
Andrea Faggiano ◽  
...  

We do not always accomplish what is best for our patients. Is “more procedures, more drugs” a real synonym of good and always useful medicine? Probably not. Indeed, it has been highlighted that many tests and treatments, widely used in medical practice, do not bring benefits to patients, but can be harmful. So, why do we keep performing them? Many reasons, surely one of the main is the constant fear of malpractice legal-medical consequences; this led to the development of a defensive medicine, no longer focused on the health of the patient. For this reason, the Italian Association of Cardiac Prevention and Rehabilitation (GICR-IACPR) joined an international project “Choosing Wisely”, supported by the Slow Medicine Initiative, a network which states that “Less is more”. The purpose of the “Choosing Wisely” project is to improve the quality and safety of health services through the reduction of practices that, according to available scientific knowledge, do not bring significant benefits to the patients, but can, on the opposite, expose them to risks. This GICR-IACPR paper proposes to avoid five widespread practices in cardiology, at risk for inappropriateness and lacking of clinical evidence of benefit: i) do not perform routine chest X-ray in patients entering rehabilitation programme after cardiac surgery; ii) do not perform Computed Tomography for coronary calcium score in patients at high cardiovascular risk; iii) do not perform Holter electrocardiographic monitoring in patients suffering from syncope, near syncope or dizziness, in whom a non-arrhythmic origin has been documented; iv) do not routinely prescribe proton pump inhibitors (PPI) for gastrointestinal bleeding prophylaxis in patient with single drug antiplatelet therapy in absence of additional risk factors; v) avoid routine use of infective endocarditis prophylaxis in mild to moderate native valve disease.


2016 ◽  
Vol 11 (38) ◽  
pp. 1-5 ◽  
Author(s):  
Julian Treadwell ◽  
Margaret McCartney

Práticas médicas ineficientes e prejudiciais sempre estiveram conosco, mas a escala e institucionalização do sobrediagnóstico e do tratamento excessivo se expandiram exponencialmente nas últimas décadas.Este tema tem sido articulado em movimentos mundiais, tais como as conferências para Prevenção de Sobrediagnóstico, e campanhas como “Medicina em Demasia” (“Too Much Medicine”), do BMJ, “Menos é Mais” (“Less is More”) da JAMA, o movimento italiano “Desacelerem a Medicina” (“Slow Medicine”) e o projeto “Escolhendo com Inteligência” (“Choosing Wisely”), dos EUA (e agora internacional). (...)


2015 ◽  
Vol 9 (3) ◽  
pp. 281 ◽  
Author(s):  
Luigi Lusiani ◽  
Roberto Frediani ◽  
Roberto Nardi ◽  
Andrea Fontanella ◽  
Mauro Campanini

Consistently with its own vision on the necessity to implement a sustainable and frugal medicine, in 2013 the Italian Federation of Associations of Hospital Doctors in Internal Medicine (FADOI) decided to adhere to the Slow Medicine program entitled <em>Doing more does not mean doing better</em>, launched in Italy in late 2012, following the Choosing Wisely® campaign of the American Board of Internal Medicine (ABIM) Foundation started in the USA in 2010. According to the program, FADOI has now produced a list of ten evidence-based recommendations of the <em>do not</em> type, regarding different practices whose benefits for the patients are questionable at least, if not harmful at worst. The list was obtained from a questionnaire submitted to 1175 FADOI members, containing a purposely selected choice of 32 pertinent recommendations already published by Choosing Wisely®, and reflects the qualified opinion of a large number of Italian internists. These recommendations are now endorsed by the FADOI, as a contribution to the discussion among doctors, health professionals, nurses, patients and citizens about what is worth choosing in medicine; they are also meant to promote a shared decision making process in the clinical practice.


2016 ◽  
Vol 36 (06) ◽  
pp. 402-406 ◽  
Author(s):  
M. Lakomek ◽  
Ch. Specker ◽  
H.-J. Lakomek

ZusammenfassungIn Anlehnung an die amerikanische “Choosing wisely”-Initiative des American Board of International Medicine (ABIM-Foundation) aus dem Jahr 2012 hat die Deutsche Gesellschaft für Innere Medizin (DGIM) mit zwölf weiteren internistischen Schwerpunkt- bzw. assoziierten Fachgesellschaften und der AWMF im Jahr 2015 fachgebietsbezogene Gesundheitsbereiche mit einer Fehlversorgung identifiziert. Auch die Deutsche Gesellschaft für Rheumatologie hat hier jeweils fünf fachbezogene Aspekte der Unter- und Überversorgung beschrieben. Dies war Anlass für die Autoren, beispielhaft zu jeweils einer Positiv- (Unterversorgung) und einer Negativ-Empfehlung (Überversorgung) Stellung zu nehmen, um die Wichtigkeit der “Klug entscheiden”-Initiative für die akutstationäre Rheumatologie aufzuzeigen. Am Beispiel der Positiv-Empfehlung (+) “Das kardiovaskuläre Risikoprofil von Patienten mit entzündlich rheumatischen Erkrankungen soll bestimmt und ggfs. reduziert werden” wird für die rheumatoide Arthritis die Bedeutung der Beachtung dieser Komorbidität aufgezeigt. Zur Unterstützung einer hohen Behandlungsqualität ist die Diagnose einer Komorbidität wie die des metabolischen Syndroms und des Typ-2-Diabetes nicht nur für die Bewertung des kardiovaskulären Risikos von Menschen mit rheumatischen Erkrankungen äußerst wichtig, sondern es kann z. B. durch Veränderung des Lebensstils und die Auswahl bestimmter Immunsuppressiva auf die sich durch die Komorbidität ergebende Prognose, z. B. bei der rheumatoiden Arthritis, positiv Einfluss genommen werden. Am Beispiel der Negativ-Empfehlung (−) “Eine längerfristige Glukokortikoidtherapie mit einer Dosis von mehr als 5 mg/die Prednisonäquivalent soll nicht durchgeführt werden” – wird die Richtigkeit der vorgeschlagenen Zielsetzung mit dem ergänzenden Hinweis aufgezeigt, bei Absenkung einer längerfristigen Glukokortikoidtherapie auf das mögliche Vorliegen einer sekundären Nebennierenrindeninsuffizienz zu achten. Die Initiative “Klug entscheiden” auch in der Rheumatologie passt gut in den Kontext der aktuellen gesundheitspolitischen Aktivitäten, über die sektorale Patientenversorgung in Deutschland eine hohe Behandlungsqualität abzusichern.


Sign in / Sign up

Export Citation Format

Share Document